All Guides
Depression Care · Quick Read
TMS vs. SPRAVATO® in 60 Seconds: How Real Patients Choose
Magnetic pulses vs. glutamate nasal spray. 20-minute drive-yourself visits vs. 2-hour REMS suite care. The fast side-by-side breakdown.
Modal Mental HealthPublished · Updated 3 min read
Two FDA-backed treatments. Two very different days.
When standard antidepressants fall short, patients most often compare TMS and SPRAVATO® (esketamine). Both are FDA-approved and covered by most commercial insurance plans, Medicare, and Medicaid—the right fit usually comes down to biology, schedule, and driving.
- How it works: TMS uses targeted magnetic pulses on mood circuits; SPRAVATO® is an intranasal spray targeting glutamate NMDA receptors.
- Time in the office: TMS takes ~18–20 minutes (or 3-min Express Theta Burst); SPRAVATO® includes dosing plus a mandatory 2-hour observation period in a private REMS suite.
- Driving home: With TMS, you drive yourself home immediately. With SPRAVATO®, you arrange a ride home and wait until the next day after a restful sleep to drive.
- Medication pairing: Both TMS and SPRAVATO® can be used on their own (monotherapy for adult TRD) or alongside an oral antidepressant, depending on your psychiatrist's clinical plan.
Still not sure? Let your evaluation do the work
You do not need to pick before you call. Start with a 45–60 minute diagnostic evaluation via New York Virtual Care or in person, get your free 1–2 day insurance check, and decide with Dr. Taner Aydin.
Common Questions
Yes. Your initial 45–60 minute psychiatric evaluation can be completed via Virtual Care from anywhere in New York State. Only TMS and SPRAVATO® treatment sessions require visiting our West Islip clinic.
More Patient Guides
All guidesDepression Care
Treatment-Resistant Depression: Comparing TMS, SPRAVATO®, and Medication Care
6 min readRead
Depression Care
5 Signs You Might Have Treatment-Resistant Depression (And Why That Label Is Actually Empowering)
4 min readRead
Depression Care
What STAR*D Taught Us About Sequenced Antidepressant Trials—and When to Pivot to Interventional Psychiatry
7 min readRead